Literature DB >> 27732689

Activity-Dependent Changes in Gene Expression in Schizophrenia Human-Induced Pluripotent Stem Cell Neurons.

Panos Roussos1, Boris Guennewig2, Dominik C Kaczorowski3, Guy Barry4, Kristen J Brennand5.   

Abstract

IMPORTANCE: Schizophrenia candidate genes participate in common molecular pathways that are regulated by activity-dependent changes in neurons. One important next step is to further our understanding on the role of activity-dependent changes of gene expression in the etiopathogenesis of schizophrenia.
OBJECTIVE: To examine whether neuronal activity-dependent changes of gene expression are dysregulated in schizophrenia. DESIGN, SETTING, AND PARTICIPANTS: Neurons differentiated from human-induced pluripotent stem cells derived from 4 individuals with schizophrenia and 4 unaffected control individuals were depolarized using potassium chloride. RNA was extracted followed by genome-wide profiling of the transcriptome. Neurons were planted on June 21, 2013, and harvested on August 2, 2013. MAIN OUTCOMES AND MEASURES: We performed differential expression analysis and gene coexpression analysis to identify activity-dependent or disease-specific changes of the transcriptome. Gene expression differences were assessed with linear models. Furthermore, we used gene set analyses to identify coexpressed modules that are enriched for schizophrenia risk genes.
RESULTS: We identified 1669 genes that were significantly different in schizophrenia-associated vs control human-induced pluripotent stem cell-derived neurons and 1199 genes that are altered in these cells in response to depolarization (linear models at false discovery rate ≤0.05). The effect of activity-dependent changes of gene expression in schizophrenia-associated neurons (59 significant genes at false discovery rate ≤0.05) was attenuated compared with control samples (594 significant genes at false discovery rate ≤0.05). Using gene coexpression analysis, we identified 2 modules (turquoise and brown) that were associated with diagnosis status and 2 modules (yellow and green) that were associated with depolarization at a false discovery rate of ≤0.05. For 3 of the 4 modules, we found enrichment with schizophrenia-associated variants: brown (χ2 = 20.68; P = .002), turquoise (χ2 = 12.95; P = .04), and yellow (χ2 = 15.34; P = .02). CONCLUSIONS AND RELEVANCE: In this analysis, candidate genes clustered within gene networks that were associated with a blunted effect of activity-dependent changes of gene expression in schizophrenia-associated neurons. Overall, these findings link schizophrenia candidate genes with specific molecular functions in neurons, which could be used to examine underlying mechanisms and therapeutic interventions related to schizophrenia.

Entities:  

Mesh:

Year:  2016        PMID: 27732689      PMCID: PMC5437975          DOI: 10.1001/jamapsychiatry.2016.2575

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  30 in total

1.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

2.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.

Authors:  Anita Rauch; Dagmar Wieczorek; Elisabeth Graf; Thomas Wieland; Sabine Endele; Thomas Schwarzmayr; Beate Albrecht; Deborah Bartholdi; Jasmin Beygo; Nataliya Di Donato; Andreas Dufke; Kirsten Cremer; Maja Hempel; Denise Horn; Juliane Hoyer; Pascal Joset; Albrecht Röpke; Ute Moog; Angelika Riess; Christian T Thiel; Andreas Tzschach; Antje Wiesener; Eva Wohlleber; Christiane Zweier; Arif B Ekici; Alexander M Zink; Andreas Rump; Christa Meisinger; Harald Grallert; Heinrich Sticht; Annette Schenck; Hartmut Engels; Gudrun Rappold; Evelin Schröck; Peter Wieacker; Olaf Riess; Thomas Meitinger; André Reis; Tim M Strom
Journal:  Lancet       Date:  2012-09-27       Impact factor: 79.321

3.  Increased exonic de novo mutation rate in individuals with schizophrenia.

Authors:  Simon L Girard; Julie Gauthier; Anne Noreau; Lan Xiong; Sirui Zhou; Loubna Jouan; Alexandre Dionne-Laporte; Dan Spiegelman; Edouard Henrion; Ousmane Diallo; Pascale Thibodeau; Isabelle Bachand; Jessie Y J Bao; Amy Hin Yan Tong; Chi-Ho Lin; Bruno Millet; Nematollah Jaafari; Ridha Joober; Patrick A Dion; Si Lok; Marie-Odile Krebs; Guy A Rouleau
Journal:  Nat Genet       Date:  2011-07-10       Impact factor: 38.330

4.  The contribution of de novo coding mutations to autism spectrum disorder.

Authors:  Ivan Iossifov; Brian J O'Roak; Stephan J Sanders; Michael Ronemus; Niklas Krumm; Dan Levy; Holly A Stessman; Kali T Witherspoon; Laura Vives; Karynne E Patterson; Joshua D Smith; Bryan Paeper; Deborah A Nickerson; Jeanselle Dea; Shan Dong; Luis E Gonzalez; Jeffrey D Mandell; Shrikant M Mane; Michael T Murtha; Catherine A Sullivan; Michael F Walker; Zainulabedin Waqar; Liping Wei; A Jeremy Willsey; Boris Yamrom; Yoon-ha Lee; Ewa Grabowska; Ertugrul Dalkic; Zihua Wang; Steven Marks; Peter Andrews; Anthony Leotta; Jude Kendall; Inessa Hakker; Julie Rosenbaum; Beicong Ma; Linda Rodgers; Jennifer Troge; Giuseppe Narzisi; Seungtai Yoon; Michael C Schatz; Kenny Ye; W Richard McCombie; Jay Shendure; Evan E Eichler; Matthew W State; Michael Wigler
Journal:  Nature       Date:  2014-10-29       Impact factor: 69.504

5.  Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia.

Authors:  K Brennand; J N Savas; Y Kim; N Tran; A Simone; K Hashimoto-Torii; K G Beaumont; H J Kim; A Topol; I Ladran; M Abdelrahim; B Matikainen-Ankney; S-h Chao; M Mrksich; P Rakic; G Fang; B Zhang; J R Yates; F H Gage
Journal:  Mol Psychiatry       Date:  2014-04-01       Impact factor: 15.992

6.  variancePartition: interpreting drivers of variation in complex gene expression studies.

Authors:  Gabriel E Hoffman; Eric E Schadt
Journal:  BMC Bioinformatics       Date:  2016-11-25       Impact factor: 3.169

7.  De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia.

Authors:  Bin Xu; Iuliana Ionita-Laza; J Louw Roos; Braden Boone; Scarlet Woodrick; Yan Sun; Shawn Levy; Joseph A Gogos; Maria Karayiorgou
Journal:  Nat Genet       Date:  2012-10-03       Impact factor: 38.330

8.  De novo mutations in epileptic encephalopathies.

Authors:  Andrew S Allen; Samuel F Berkovic; Patrick Cossette; Norman Delanty; Dennis Dlugos; Evan E Eichler; Michael P Epstein; Tracy Glauser; David B Goldstein; Yujun Han; Erin L Heinzen; Yuki Hitomi; Katherine B Howell; Michael R Johnson; Ruben Kuzniecky; Daniel H Lowenstein; Yi-Fan Lu; Maura R Z Madou; Anthony G Marson; Heather C Mefford; Sahar Esmaeeli Nieh; Terence J O'Brien; Ruth Ottman; Slavé Petrovski; Annapurna Poduri; Elizabeth K Ruzzo; Ingrid E Scheffer; Elliott H Sherr; Christopher J Yuskaitis; Bassel Abou-Khalil; Brian K Alldredge; Jocelyn F Bautista; Samuel F Berkovic; Alex Boro; Gregory D Cascino; Damian Consalvo; Patricia Crumrine; Orrin Devinsky; Dennis Dlugos; Michael P Epstein; Miguel Fiol; Nathan B Fountain; Jacqueline French; Daniel Friedman; Eric B Geller; Tracy Glauser; Simon Glynn; Sheryl R Haut; Jean Hayward; Sandra L Helmers; Sucheta Joshi; Andres Kanner; Heidi E Kirsch; Robert C Knowlton; Eric H Kossoff; Rachel Kuperman; Ruben Kuzniecky; Daniel H Lowenstein; Shannon M McGuire; Paul V Motika; Edward J Novotny; Ruth Ottman; Juliann M Paolicchi; Jack M Parent; Kristen Park; Annapurna Poduri; Ingrid E Scheffer; Renée A Shellhaas; Elliott H Sherr; Jerry J Shih; Rani Singh; Joseph Sirven; Michael C Smith; Joseph Sullivan; Liu Lin Thio; Anu Venkat; Eileen P G Vining; Gretchen K Von Allmen; Judith L Weisenberg; Peter Widdess-Walsh; Melodie R Winawer
Journal:  Nature       Date:  2013-08-11       Impact factor: 49.962

9.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

10.  The Reactome pathway Knowledgebase.

Authors:  Antonio Fabregat; Konstantinos Sidiropoulos; Phani Garapati; Marc Gillespie; Kerstin Hausmann; Robin Haw; Bijay Jassal; Steven Jupe; Florian Korninger; Sheldon McKay; Lisa Matthews; Bruce May; Marija Milacic; Karen Rothfels; Veronica Shamovsky; Marissa Webber; Joel Weiser; Mark Williams; Guanming Wu; Lincoln Stein; Henning Hermjakob; Peter D'Eustachio
Journal:  Nucleic Acids Res       Date:  2015-12-09       Impact factor: 16.971

View more
  21 in total

Review 1.  Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs).

Authors:  Haneul Noh; Zhicheng Shao; Joseph T Coyle; Sangmi Chung
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-28       Impact factor: 5.187

2.  Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).

Authors:  S T Narla; Y-W Lee; C A Benson; P Sarder; K J Brennand; E K Stachowiak; M K Stachowiak
Journal:  Schizophr Res       Date:  2017-01-13       Impact factor: 4.939

3.  Research Domain Criteria: Strengths, Weaknesses, and Potential Alternatives for Future Psychiatric Research.

Authors:  Christopher A Ross; Russell L Margolis
Journal:  Mol Neuropsychiatry       Date:  2019-08-13

Review 4.  Stem cell-based models and therapies: a key approach into schizophrenia treatment.

Authors:  Bagher Larijani; Peyvand Parhizkar Roudsari; Mahdieh Hadavandkhani; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Forough Azam Sayahpour; Fereshteh Mohamadi-Jahani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2021-01-02       Impact factor: 1.522

5.  Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia.

Authors:  Annie Kathuria; Kara Lopez-Lengowski; Smita S Jagtap; Donna McPhie; Roy H Perlis; Bruce M Cohen; Rakesh Karmacharya
Journal:  JAMA Psychiatry       Date:  2020-07-01       Impact factor: 21.596

Review 6.  Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells.

Authors:  Samuel K Powell; Callan P O'Shea; Sara Rose Shannon; Schahram Akbarian; Kristen J Brennand
Journal:  Adv Neurobiol       Date:  2020

7.  Identifying Subgroups of Patients With Autism by Gene Expression Profiles Using Machine Learning Algorithms.

Authors:  Ping-I Lin; Mohammad Ali Moni; Susan Shur-Fen Gau; Valsamma Eapen
Journal:  Front Psychiatry       Date:  2021-05-12       Impact factor: 4.157

8.  Using Human iPSC-Derived Neurons to Uncover Activity-Dependent Non-Coding RNAs.

Authors:  Mainá Bitar; Stefanie Kuiper; Elizabeth O'Brien; Guy Barry
Journal:  Genes (Basel)       Date:  2017-12-20       Impact factor: 4.096

Review 9.  Stem Cells for Improving the Treatment of Neurodevelopmental Disorders.

Authors:  Jennifer J Donegan; Daniel J Lodge
Journal:  Stem Cells Dev       Date:  2020-03-05       Impact factor: 3.272

10.  Dopaminergic organization of striatum is linked to cortical activity and brain expression of genes associated with psychiatric illness.

Authors:  Robert A McCutcheon; Kirsten Brown; Matthew M Nour; Stephen M Smith; Mattia Veronese; Fernando Zelaya; Martin Osugo; Sameer Jauhar; William Hallett; Mitul M Mehta; Oliver D Howes
Journal:  Sci Adv       Date:  2021-06-09       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.